Skip to main content
Signal8

GELSTAT CORP (GSAC)

GelStat Corporation operates as a consumer healthcare enterprise, specializing in the innovation, formulation, and commercialization of over-the-counter (OTC) and other non-prescription health solutions. Its diverse product portfolio addresses various common health concerns, featuring: GelStat Migraine, a patented remedy targeting migraine headache pain; Chews 2 Lose, an appetite-controlling gum designed to assist with weight management; All Natural Speed, formulated as an energy booster; and GelStat Sleep, intended to alleviate sleep disturbances and their related symptoms. GelStat distributes its solutions through a comprehensive network, reaching retailers, wholesalers, specialized distributors, and catalog merchandisers. This is achieved both through direct sales and via independent sales brokerage agreements. The corporation maintains its principal office in Palm City, Florida.

Sector: Pharmaceutical Preparations

Industry: Medical - Pharmaceuticals

GelStat Corporation logo

GelStat Corporation

OTC:GSACHealthcare
$0.0003
Mkt Cap$185K
Float530.21M
O/S617.98M
Inst Own-
SI<0.1%
Dilution
FormDescription
1-Z
SEC Filing
1-U
9.1
1-SA
SEC Filing
1-K
SEC Filing
1-SA
SEMI ANNUAL REPORT
1-K
SEC Filing
1-U
9.2
1-SA
SEMI ANNUAL REPORT
1-K
SEC Filing
1-U
CURRENT REPORT
1-SA
SEMI ANNUAL REPORT
1-K
SEC Filing
4
Statement of Changes in Beneficial Ownership
3
Initial Statement of Beneficial Ownership
QUALIF
SEC Filing
CORRESP
SEC Filing
1-A/A
SEC Filing
1-A/A
SEC Filing
UPLOAD
SEC Filing
1-A
SEC Filing
UPLOAD
SEC Filing
10-K/A
Annual Report (Amended)
10-K/A
Annual Report (Amended)
UPLOAD
SEC Filing
10-K
Annual Report

1-25 of 190

…